Does the level of myocardial injury differ in primary angioplasty patients loaded first with clopidogrel and the ones with ticagrelor?

Creative Commons License

ÖZYÜNCÜ N., Goksuluk H., TAN T. S., ESENBOĞA K., ATMACA Y., EROL Ç.

ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.24, sa.2, ss.107-112, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 24 Sayı: 2
  • Basım Tarihi: 2020
  • Doi Numarası: 10.14744/anatoljcardiol.2020.22903
  • Dergi Adı: ANATOLIAN JOURNAL OF CARDIOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.107-112
  • Anahtar Kelimeler: clopidogrel, STEMI, ticagrelor, myocardial injury, PERCUTANEOUS CORONARY INTERVENTION, ST-SEGMENT ELEVATION, PLATELET INHIBITION, EARLY-DIAGNOSIS, DELTA TROPONIN, 2017 ESC, INFARCTION, CONSENSUS, INSIGHTS
  • Ankara Üniversitesi Adresli: Evet

Özet

Objective: In daily clinical practice, we encounter ST segment elevation myocardial infarction (STEMI) patients loaded with clopidogrel upon admission to primary angioplasty. These patients are loaded with ticagrelor, if there is no contraindication. This study aimed to compare the level of injury between STEMI patients who were first loaded with clopidogrel and the ones first loaded with ticagrelor. Although patients were switched from clopidogrel to ticagrelor at the first hour of angioplasty, antiplatelet action may still be lower than the others.